Antimicrobial Agents Practice Questions

Q: What is the drug of choice for anaerobic infections?

Metronidazole. **Explanation:** **Metronidazole** is the drug of choice for infections caused by **obligate anaerobes** (e.g., *Bacteroides fragilis*, *Clostridium difficile*, *Fusobacterium*). Its mechanism involves the reduction of its nitro group by the enzyme **pyruvate:ferredoxin oxidoreductase (PFOR)**, which is found only in anaerobic organisms. This process generates reactive free radicals that cause DNA strand breakage and cell death. **Analysis of Options:** * **Amphotericin B:** This is a polyene **antifungal** agent used for systemic fungal infections (e.g., Mucormycosis, Cryptococcosis). It has no activity against bacteria. * **Aminoglycosides (e.g., Gentamicin):** These are ineffective against anaerobes because their uptake into the bacterial cell is an **oxygen-dependent process**. They are primarily used for aerobic Gram-negative bacilli. * **Macrolides (e.g., Azithromycin):** These are mainly used for aerobic Gram-positive cocci and atypical organisms (e.g., *Mycoplasma*, *Chlamydia*). While some have minor activity against certain anaerobes, they are never the first-line choice. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram-like reaction:** Patients must avoid alcohol while on Metronidazole due to the inhibition of aldehyde dehydrogenase. * **Coverage Rule:** For anaerobic infections "above the diaphragm" (e.g., aspiration pneumonia), **Clindamycin** is often preferred; for "below the diaphragm" (e.g., intra-abdominal abscess), **Metronidazole** is the gold standard. * **Other uses:** It is also the drug of choice for Amoebiasis, Giardiasis, Trichomoniasis, and Bacterial Vaginosis.

Q: What is the drug of choice for Gardnerella vaginalis infections?

Metronidazole. **Explanation:** **1. Why Metronidazole is the Correct Answer:** *Gardnerella vaginalis* is the primary organism associated with **Bacterial Vaginosis (BV)**. Although it is a facultative anaerobe, it thrives in the anaerobic environment created when the normal vaginal flora (*Lactobacilli*) is depleted. **Metronidazole** is the drug of choice because it is highly effective against anaerobic bacteria. It acts as a prodrug that is activated by the microbial enzyme pyruvate-ferredoxin oxidoreductase, leading to the formation of reactive toxic intermediates that cause DNA strand breakage. **2. Why the Other Options are Incorrect:** * **Ampicillin:** While it has some activity against *G. vaginalis*, it is less effective than metronidazole and is associated with higher recurrence rates. It is generally reserved for pregnant patients who cannot tolerate nitroimidazoles. * **Vancomycin:** This is a glycopeptide used primarily for Gram-positive infections (like MRSA) and *C. difficile* colitis. It has no role in treating Bacterial Vaginosis. * **Cephalosporins:** These are beta-lactam antibiotics used for a wide range of infections, but they do not provide the specific anaerobic coverage required to effectively eradicate the polymicrobial biofilm associated with BV. **3. High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** BV is diagnosed using **Amsel’s Criteria** (requires 3 out of 4): 1. Thin, homogenous discharge; 2. Vaginal pH >4.5; 3. Positive **Whiff test** (fishy odor with 10% KOH); 4. Presence of **Clue cells** on microscopy. * **Treatment Regimen:** Oral Metronidazole 500 mg twice daily for 7 days (or 0.75% metronidazole gel). * **Important Side Effect:** Patients must be warned about the **Disulfiram-like reaction** (nausea, vomiting, flushing) if alcohol is consumed during metronidazole therapy. * **Pregnancy:** Metronidazole is safe to use in all trimesters of pregnancy for symptomatic BV.

Q: What is the incidence of allergy to penicillin among various populations?

1% to 10%. Penicillin allergy is the most commonly reported drug allergy in clinical practice. According to standard pharmacological texts (like Goodman & Gilman and Katzung), the reported incidence of penicillin hypersensitivity ranges from **1% to 10%** in the general population. **Explanation of the Correct Answer:** The correct range is **1% to 10% (Option A)**. This encompasses a wide spectrum of reactions, from mild skin rashes to life-threatening anaphylaxis. It is important to note that while 10% of patients *report* an allergy, skin testing reveals that approximately 90% of these individuals are actually tolerant and can safely receive the drug. The true incidence of IgE-mediated anaphylaxis is much lower, occurring in only about 0.01% to 0.05% of treatments. **Why Other Options are Incorrect:** * **Options B, C, and D (10% to 40%):** These ranges significantly overestimate the prevalence. Even in populations with high drug exposure, the incidence of documented hypersensitivity rarely exceeds 10%. Over-diagnosing penicillin allergy leads to the use of broader-spectrum, more expensive, or more toxic alternatives (like Vancomycin or Clindamycin), contributing to antimicrobial resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Most reactions are Type I (IgE-mediated) or Type IV (delayed hypersensitivity). * **Cross-Reactivity:** The risk of cross-reactivity between penicillins and **1st generation cephalosporins** is approximately **3-5%** (historically cited as 10%). It is much lower (<1%) with 3rd and 4th generation cephalosporins. * **Monobactams:** Aztreonam is the only beta-lactam that generally does **not** cross-react with penicillins (except for a specific cross-sensitivity with Ceftazidime). * **Determinants:** The "Major Determinant" of penicillin allergy is **Penicilloyl** (used in skin testing).

Q: Which drug is most likely to be responsible for causing pancreatic disease?

Didanosine. ### Explanation **Correct Option: A. Didanosine** Didanosine (ddI) is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in HIV treatment [1]. Its most notorious and dose-limiting adverse effect is **acute pancreatitis** [1], [3]. The underlying mechanism involves mitochondrial toxicity due to the inhibition of DNA polymerase-gamma, leading to pancreatic acinar cell damage [2]. Patients on Didanosine must be monitored for elevated serum amylase and lipase levels; the drug should be discontinued immediately if pancreatitis is suspected [1]. **Analysis of Incorrect Options:** * **B. Ketoconazole:** This is an azole antifungal primarily known for causing **hepatotoxicity** and inhibiting steroidogenesis (leading to gynecomastia and menstrual irregularities) by inhibiting the CYP450 system. It is not associated with pancreatic disease. * **C. Saquinavir:** This is a Protease Inhibitor (PI). While PIs are associated with metabolic complications like dyslipidemia, insulin resistance, and **lipodystrophy** (buffalo hump), they are not the primary cause of acute pancreatitis compared to Didanosine. * **D. Zidovudine (AZT):** Also an NRTI, but its hallmark toxicity is **bone marrow suppression** (anemia and neutropenia) and myopathy [3]. While it can cause lactic acidosis, it is not a classic cause of pancreatitis. **High-Yield Clinical Pearls for NEET-PG:** * **NRTI Toxicity Mnemonic:** * **D**idanosine & **S**tavudine = **D**igits and **S**tomach (**P**eripheral neuropathy and **P**ancreatitis) [3]. * **Z**idovudine = **7**idovudine (low blood counts/Anemia). * **A**bacavir = **H**ypersensitivity reaction (linked to HLA-B*5701). * Other drugs causing pancreatitis: **S**ulfonamides, **E**strogens, **V**alproic acid, **E**xenatide, **R**itonavir, **E**nalapril (**SEVERE**).

Q: Which of the following antitubercular drugs can be safely used in severe renal failure?

Rifampicin. **Explanation:** The management of tuberculosis in patients with renal impairment requires careful drug selection based on the primary route of elimination. **Why Rifampicin is the correct answer:** Rifampicin is primarily metabolized by the liver and excreted via the **bile/feces**. Since its clearance is not significantly dependent on renal function, it can be used in standard doses even in patients with severe renal failure or those on hemodialysis. Along with **Isoniazid and Pyrazinamide**, it is considered safe for use in renal failure, although the latter two are sometimes adjusted to thrice-weekly dosing in end-stage renal disease to prevent metabolite accumulation. **Why the other options are incorrect:** * **Streptomycin & Capreomycin:** Both are aminoglycosides (or aminoglycoside-like) and are strictly **excreted unchanged by the kidneys**. In renal failure, they accumulate rapidly, leading to severe ototoxicity and further nephrotoxicity. They are generally contraindicated or require extreme dose reduction and monitoring. * **Ethambutol:** Approximately 80% of ethambutol is excreted via the kidneys. In renal failure, it accumulates and significantly increases the risk of **optic neuritis**. If used, the dosing interval must be increased (e.g., thrice weekly instead of daily). **NEET-PG High-Yield Pearls:** * **Safe in Renal Failure:** Rifampicin, Isoniazid, Pyrazinamide, and Ethionamide (mainly hepatic metabolism). * **Requires Dose Adjustment:** Ethambutol and Levofloxacin. * **Avoid/Contraindicated:** Streptomycin and other injectable aminoglycosides. * **Rifampicin Fact:** It is a potent **enzyme inducer** (CYP450), but it is also the most important drug for treating "persisters" in TB due to its bactericidal action.

Q: Which among the following is the drug of choice in Mycoplasma infection?

Doxycycline. **Explanation:** The correct answer is **Doxycycline**. **1. Why Doxycycline is the Drug of Choice:** *Mycoplasma pneumoniae* is a unique pathogen characterized by the **complete absence of a cell wall**. Because it lacks a peptidoglycan layer, it is inherently resistant to all cell-wall synthesis inhibitors. Treatment must focus on protein synthesis inhibitors. **Tetracyclines (like Doxycycline)** and Macrolides (like Azithromycin) are the first-line agents. Doxycycline is highly effective due to its excellent tissue penetration and ability to inhibit the 30S ribosomal subunit. **2. Why the other options are incorrect:** * **Penicillin & Ceftriaxone (Beta-lactams):** These drugs act by inhibiting cell wall synthesis (binding to Penicillin-Binding Proteins). Since *Mycoplasma* has no cell wall, these drugs have no target site and are clinically useless. * **Cotrimoxazole:** This drug inhibits folic acid synthesis. While effective against many bacteria, it is not the standard of care for *Mycoplasma*, as Tetracyclines and Macrolides show superior clinical outcomes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Atypical Pneumonia:** *Mycoplasma* is the most common cause of "Walking Pneumonia," typically presenting with a persistent dry cough and patchy infiltrates on X-ray that look worse than the patient’s clinical state. * **Diagnosis:** The **Cold Agglutinin Test** (IgM antibodies) is a classic bedside test, though PCR is now the gold standard. * **Complications:** Look for **Erythema Multiforme** or Stevens-Johnson Syndrome as a rare but high-yield dermatological association. * **Alternative:** In children and pregnant women (where Tetracyclines are contraindicated), **Azithromycin** is the preferred alternative.

Q: Which of the following drugs is NOT indicated in MRSA infection?

Imipenem. ### Explanation **Correct Option: D. Imipenem** **Why Imipenem is the correct answer:** Methicillin-resistant *Staphylococcus aureus* (MRSA) is defined by its resistance to almost all **$eta$-lactam antibiotics** (penicillins, cephalosporins, and carbapenems). This resistance is mediated by the **mecA gene**, which encodes an altered **Penicillin-Binding Protein (PBP2a)**. Standard $eta$-lactams, including **Imipenem** (a carbapenem), have a low affinity for PBP2a and therefore cannot inhibit cell wall synthesis in MRSA. *Note: The only $eta$-lactams effective against MRSA are the 5th generation cephalosporins (e.g., Ceftaroline, Ceftobiprole).* **Why the other options are incorrect:** * **A & B (Vancomycin & Teicoplanin):** These are Glycopeptides. They inhibit cell wall synthesis by binding to the D-Ala-D-Ala terminus of nascent peptidoglycan. They do not rely on PBPs for their action, making them the traditional "gold standard" for MRSA [2]. * **C (Linezolid):** This is an Oxazolidinone that inhibits protein synthesis (50S subunit). It is highly effective against MRSA and is particularly useful for MRSA-induced pneumonia due to its excellent lung penetration [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Vancomycin remains the DOC for systemic MRSA infections [2]. * **Alternative for VRSA:** If a strain is resistant to Vancomycin (VRSA), **Linezolid** or **Daptomycin** are used [1], [2]. * **Daptomycin Caution:** Never use Daptomycin for MRSA pneumonia because it is inactivated by pulmonary surfactant. * **Rapid Screening:** Cefoxitin disk diffusion is the preferred method to detect MRSA in the lab.

Q: Which drug is more potent and less toxic against herpes viruses?

Acyclovir. **Explanation:** **Acyclovir** is the correct answer because of its unique **selective toxicity** mechanism. It is a guanosine analogue that acts as a "prodrug." Its activation requires a viral-specific enzyme, **Thymidine Kinase (TK)**, to convert it into acyclovir monophosphate. Since host cells lack this viral TK, the drug remains inactive in non-infected cells. It is then further phosphorylated by host cell kinases to acyclovir triphosphate, which causes DNA chain termination by inhibiting viral DNA polymerase. This high selectivity makes it highly potent against HSV-1, HSV-2, and VZV while remaining remarkably non-toxic to human cells. **Analysis of Incorrect Options:** * **Zidovudine (AZT):** A Nucleoside Reverse Transcriptase Inhibitor (NRTI) used primarily for **HIV**. While it also causes chain termination, it is not the drug of choice for Herpes and carries significant toxicity (e.g., bone marrow suppression). * **Nystatin:** A polyene **antifungal** agent used for *Candida* infections. It works by binding to ergosterol in fungal cell membranes and has no activity against viruses. * **Amantadine:** An **anti-influenza** drug (and anti-Parkinsonian agent) that inhibits the M2 protein ion channel. It is ineffective against the Herpesviridae family. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** Most common cause of Acyclovir resistance is the absence or mutation of viral **Thymidine Kinase**. * **Drug of Choice:** Acyclovir is the DOC for Herpes Simplex Encephalitis and Genital Herpes. * **Valacyclovir:** A prodrug of acyclovir with much higher oral bioavailability (used to improve dosing compliance). * **Side Effect:** Rapid IV infusion can cause **crystalline nephropathy**; ensure adequate hydration.

Question 1

What is the drug of choice for anaerobic infections?

Accepted Answer

Metronidazole

Answer

Amphotericin B

Answer

Aminoglycoside

Answer

Macrolide

Question 2

What is the drug of choice for Gardnerella vaginalis infections?

Accepted Answer

Metronidazole

Answer

Ampicillin

Answer

Vancomycin

Answer

Cephalosporin

Question 3

What is the incidence of allergy to penicillin among various populations?

Accepted Answer

1% to 10%

Answer

10% to 20%

Answer

20% to 30%

Answer

30% to 40%

Question 4

Which drug is most likely to be responsible for causing pancreatic disease?

Accepted Answer

Didanosine

Answer

Ketoconazole

Answer

Saquinavir

Answer

Zidovudine

Question 5

Which of the following antitubercular drugs can be safely used in severe renal failure?

Accepted Answer

Rifampicin

Answer

Streptomycin

Answer

Ethambutol

Answer

Capreomycin

Question 6

Regarding the antibacterial action of gentamicin, which of the following statements is most accurate?

Accepted Answer

Gentamicin continues to exert antibacterial effects even after plasma levels decrease below detectable range.

Answer

Efficacy is directly proportionate to the time that the plasma level of the drug is greater than the minimal inhibitory concentration.

Answer

Antibacterial activity is often reduced by the presence of an inhibitor of cell wall synthesis.

Answer

The antibacterial action of gentamicin is time dependent.

Question 7

Which among the following is the drug of choice in Mycoplasma infection?

Accepted Answer

Doxycycline

Answer

Penicillin

Answer

Ceftriaxone

Answer

Cotrimoxazole

Question 8

Which of the following drugs is NOT indicated in MRSA infection?

Accepted Answer

Imipenem

Answer

Vancomycin

Answer

Teicoplanin

Answer

Linezolid

Question 9

Which drug is more potent and less toxic against herpes viruses?

Accepted Answer

Acyclovir

Answer

Zidovudine

Answer

Nystatin

Answer

Amantidine

Question 10

Which drugs are recommended by WHO for Artemisinin-based combination therapy?

Accepted Answer

Dihydroartemisinin plus piperaquine

Answer

Atremether plus proguanil

Answer

Artesunate plus doxycycline

Answer

Artesunate plus piperaquine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?